Copyright Reports & Markets. All rights reserved.

Global Immunotherapy Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Immunotherapy Market Overview

      • 1.1 Product Overview and Scope of Immunotherapy
      • 1.2 Immunotherapy Segment by Type
        • 1.2.1 Global Immunotherapy Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Monoclonal Antibodies
        • 1.2.3 Therapeutic Vaccines
        • 1.2.4 Checkpoint Inhibitors
        • 1.2.5 Non-Specific Immunotherapy
      • 1.3 Immunotherapy Segment by Application
        • 1.3.1 Immunotherapy Consumption Comparison by Application (2014-2025)
        • 1.3.2 Oncology
        • 1.3.3 Inflammation
        • 1.3.4 Central Nervous System
        • 1.3.5 Others
      • 1.4 Global Immunotherapy Market by Region
        • 1.4.1 Global Immunotherapy Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Immunotherapy Market Size
        • 1.5.1 Global Immunotherapy Revenue (2014-2025)
        • 1.5.2 Global Immunotherapy Production (2014-2025)

      2 Global Immunotherapy Market Competition by Manufacturers

      • 2.1 Global Immunotherapy Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Immunotherapy Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Immunotherapy Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Immunotherapy Production Sites, Area Served, Product Types
      • 2.5 Immunotherapy Market Competitive Situation and Trends
        • 2.5.1 Immunotherapy Market Concentration Rate
        • 2.5.2 Immunotherapy Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Immunotherapy Production Market Share by Regions

      • 3.1 Global Immunotherapy Production Market Share by Regions
      • 3.2 Global Immunotherapy Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Immunotherapy Production
        • 3.4.1 North America Immunotherapy Production Growth Rate (2014-2019)
        • 3.4.2 North America Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Immunotherapy Production
        • 3.5.1 Europe Immunotherapy Production Growth Rate (2014-2019)
        • 3.5.2 Europe Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Immunotherapy Production (2014-2019)
        • 3.6.1 China Immunotherapy Production Growth Rate (2014-2019)
        • 3.6.2 China Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Immunotherapy Production (2014-2019)
        • 3.7.1 Japan Immunotherapy Production Growth Rate (2014-2019)
        • 3.7.2 Japan Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Immunotherapy Consumption by Regions

      • 4.1 Global Immunotherapy Consumption by Regions
      • 4.2 North America Immunotherapy Consumption (2014-2019)
      • 4.3 Europe Immunotherapy Consumption (2014-2019)
      • 4.4 China Immunotherapy Consumption (2014-2019)
      • 4.5 Japan Immunotherapy Consumption (2014-2019)

      5 Global Immunotherapy Production, Revenue, Price Trend by Type

      • 5.1 Global Immunotherapy Production Market Share by Type (2014-2019)
      • 5.2 Global Immunotherapy Revenue Market Share by Type (2014-2019)
      • 5.3 Global Immunotherapy Price by Type (2014-2019)
      • 5.4 Global Immunotherapy Production Growth by Type (2014-2019)

      6 Global Immunotherapy Market Analysis by Applications

      • 6.1 Global Immunotherapy Consumption Market Share by Application (2014-2019)
      • 6.2 Global Immunotherapy Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Immunotherapy Business

      • 7.1 Abbvie
        • 7.1.1 Abbvie Immunotherapy Production Sites and Area Served
        • 7.1.2 Immunotherapy Product Introduction, Application and Specification
        • 7.1.3 Abbvie Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Amgen, Inc.
        • 7.2.1 Amgen, Inc. Immunotherapy Production Sites and Area Served
        • 7.2.2 Immunotherapy Product Introduction, Application and Specification
        • 7.2.3 Amgen, Inc. Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Biogen
        • 7.3.1 Biogen Immunotherapy Production Sites and Area Served
        • 7.3.2 Immunotherapy Product Introduction, Application and Specification
        • 7.3.3 Biogen Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Bristol-Myers Squibb
        • 7.4.1 Bristol-Myers Squibb Immunotherapy Production Sites and Area Served
        • 7.4.2 Immunotherapy Product Introduction, Application and Specification
        • 7.4.3 Bristol-Myers Squibb Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Celgene
        • 7.5.1 Celgene Immunotherapy Production Sites and Area Served
        • 7.5.2 Immunotherapy Product Introduction, Application and Specification
        • 7.5.3 Celgene Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Johnson & Johnson
        • 7.6.1 Johnson & Johnson Immunotherapy Production Sites and Area Served
        • 7.6.2 Immunotherapy Product Introduction, Application and Specification
        • 7.6.3 Johnson & Johnson Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Merck
        • 7.7.1 Merck Immunotherapy Production Sites and Area Served
        • 7.7.2 Immunotherapy Product Introduction, Application and Specification
        • 7.7.3 Merck Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Novartis
        • 7.8.1 Novartis Immunotherapy Production Sites and Area Served
        • 7.8.2 Immunotherapy Product Introduction, Application and Specification
        • 7.8.3 Novartis Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Pfizer
        • 7.9.1 Pfizer Immunotherapy Production Sites and Area Served
        • 7.9.2 Immunotherapy Product Introduction, Application and Specification
        • 7.9.3 Pfizer Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Roche
        • 7.10.1 Roche Immunotherapy Production Sites and Area Served
        • 7.10.2 Immunotherapy Product Introduction, Application and Specification
        • 7.10.3 Roche Immunotherapy Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served

      8 Immunotherapy Manufacturing Cost Analysis

      • 8.1 Immunotherapy Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Immunotherapy
      • 8.4 Immunotherapy Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Immunotherapy Distributors List
      • 9.3 Immunotherapy Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Immunotherapy Market Forecast

      • 11.1 Global Immunotherapy Production, Revenue Forecast
        • 11.1.1 Global Immunotherapy Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Immunotherapy Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Immunotherapy Price and Trend Forecast (2019-2025)
      • 11.2 Global Immunotherapy Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Immunotherapy Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Immunotherapy Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Immunotherapy Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Immunotherapy Production, Revenue Forecast (2019-2025)
      • 11.3 Global Immunotherapy Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Immunotherapy Consumption Forecast (2019-2025)
        • 11.3.2 Europe Immunotherapy Consumption Forecast (2019-2025)
        • 11.3.3 China Immunotherapy Consumption Forecast (2019-2025)
        • 11.3.4 Japan Immunotherapy Consumption Forecast (2019-2025)
      • 11.4 Global Immunotherapy Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Immunotherapy Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Immunotherapy is the treatment given to suppress or amplify the immune response of a person using immunomodulators. The amplification of immune response is called as activation immunotherapy and the suppression of the immune response is called suppression immunotherapy.

        The global Immunotherapy market is valued at 106900 million US$ in 2018 is expected to reach 179100 million US$ by the end of 2025, growing at a CAGR of 6.7% during 2019-2025.
        This report focuses on Immunotherapy volume and value at global level, regional level and company level. From a global perspective, this report represents overall Immunotherapy market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Abbvie
        Amgen, Inc.
        Biogen
        Bristol-Myers Squibb
        Celgene
        Johnson & Johnson
        Merck
        Novartis
        Pfizer
        Roche

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Monoclonal Antibodies
        Therapeutic Vaccines
        Checkpoint Inhibitors
        Non-Specific Immunotherapy

        Segment by Application
        Oncology
        Inflammation
        Central Nervous System
        Others

        Buy now